DOI:
10.1055/s-00000075
Seminars in Respiratory and Critical Care Medicine
LinksClose Window
References
Gavin PJ, Suseno MT, Thomson Jr RB , et al.
Clinical correlation of the CLSI susceptibility breakpoint for piperacillin- tazobactam against extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella species.
Antimicrob Agents Chemother 2006;
50 (6) 2244-2247
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.